Role of 18F-FDG-PET/CT in establishing new clinical and therapeutic modalities in lung cancer. a short review

RCD Bolton, AK Calapaquí-Terán, F Giammarile… - Revista Española de …, 2019 - Elsevier
Lung cancer is a fairly common malignancy. An early diagnosis and a reliable staging and
re-staging with the aim to detect both local and distant relapse are of utmost importance in …

Impact of 18F-FDG PET/CT on the treatment of patients with non-small cell lung cancer

Á Taus, R Aguiló, V Curull, M Suarez-Pinera… - Archivos de …, 2014 - Elsevier
Introduction Disease stage is the most important prognostic factor in lung cancer, and
optimal staging is important to determine the best therapeutic option. FDG-PET/CT has …

Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer

PH Madsen, PC Holdgaard, JB Christensen… - European journal of …, 2016 - Springer
Purpose Positron emission tomography-computed tomography (PET-CT) is a resource-
demanding imaging modality with increasing popularity in the workup of patients with …

18F-FDG PET/CT in lung cancer. The added value of quantification

P Lapa, M Marques, J Isidoro, F Barata, G Costa… - Revista Española de …, 2017 - Elsevier
Objective To test a software application for the quantification of metabolic heterogeneity and
to evaluate its superiority in relation to visual interpretation. To investigate if a quantitative …

Benefits of respiratory-gated 18F-FDG PET acquisition in lung disease

P Bailly, R Bouzerar, T Shields… - Nuclear Medicine …, 2018 - journals.lww.com
Background Fluorine-18-fluorodeoxyglucose (18 F-FDG) PET/computed tomography (CT) is
a reliable imaging modality for the diagnosis of malignant lung nodules and to assess the …

The role of PET/CT molecular imaging in the diagnosis of recurrence and surveillance of patients treated for non-small cell lung cancer

JF Jiménez-Bonilla, R Quirce, I Martínez-Rodríguez… - Diagnostics, 2016 - mdpi.com
Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality worldwide and
its prognosis remains poor. Molecular imaging with 18F-FDG PET/CT can metabolically …

[HTML][HTML] The contribution of fluorine 18F-FDG PET/CT to lung cancer diagnosis, staging and treatment planning

E Budak, G Çok, A Akgün - Molecular imaging and radionuclide …, 2018 - ncbi.nlm.nih.gov
Objective: Lung cancer is the most common cause of cancer-related death throughout the
world, and the correct choice of treatment based on early diagnosis and staging increases …

PET/MRI and PET/CT in lung lesions and thoracic malignancies

P Flechsig, A Mehndiratta, U Haberkorn… - Seminars in nuclear …, 2015 - Elsevier
More than one decade ago, introduction of integrated PET/CT scanners changed oncologic
imaging and oncologic patient management profoundly. With these systems, the metabolic …

Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer

W Yang, Y Zhang, Z Fu, J Yu, X Sun, D Mu… - European journal of …, 2010 - Springer
Purpose To compare the diagnostic efficacies of 18 F-FLT and 18 F-FDG PET/CT in non-
small-cell lung cancer (NSCLC), focusing on the correlation between FLT and FDG tumour …

Evaluation of dual–time-point 18F-FDG PET for staging in patients with lung cancer

D Uesaka, Y Demura, T Ishizaki… - Journal of Nuclear …, 2008 - Soc Nuclear Med
18F-FDG PET is increasingly used for lung cancer; however, some insufficient results have
been reported. The purpose of this study was to evaluate the efficacy of dual–time-point 18F …